Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back



Meet Our Editorial Board Member free to download

Volume:17   Issue:4
Pp: 303-303
Thomas W. Grunt*
DOI: 10.2174/156800961704170419204900



Synthetic Lethal Interactions in Cancer Therapy

Volume:17   Issue:4
Pp: 304-310
Xinwei Geng, Xiaohui Wang, Dan Zhu* and Songmin Ying*
DOI: 10.2174/1568009616666160426122736



Chemotherapy and Cardiotoxicity in Hematologic Malignancies

Volume:17   Issue:4
Pp: 311-324
Antonio Stellitano, Roberta Fedele, Santina Barilla, Antonino Iaria, Carmelo Massimiliano Rao and Massimo Martino*
DOI: 10.2174/1568009617666161121141607



New Candidate Genes for Lack of Sensitivity to Therapy in Pediatric Leukemias

Volume:17   Issue:4
Pp: 333-343
Weronika Bereza, Joanna Szczepanek*, Joanna Laskowska and Andrzej Tretyn
DOI: 10.2174/1568009616666161208150148



Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy

Volume:17   Issue:4
Pp: 344-356
Heena Singla, Sourav Kalra, Preeti Kheterpal, Vinod Kumar* and Anjana Munshi*
DOI: 10.2174/1568009616666161216094026